Is Clearpoint Neuro Inc (CLPT) overvalued? · rev $31.4M
Clearpoint Neuro Inc (CLPT) is a medical devices company listed on US.
This page asks whether Clearpoint Neuro Inc (CLPT) looks expensive on cached numbers — not a short thesis.
Latest reported CLPT revenue for 2024-12-31 was $31.4M. Net income was -$18.9M. Revenue was up 31.0% from 2023-12-31 to 2024-12-31. CLPT currently screens at market cap $371.0M.
CLPT currently screens at market cap $371.0M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next CLPT 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the CLPT stock page for the full model, not this heading.
Not investment advice.